Knight M, Tuffnell D, Kenyon S, Shakespeare J, Gray R, Kurinczuk J, on behalf of MBRRACE-UK. Saving lives, improving mothers’ care - surveillance of maternal deaths in the UK 2011–13 and lessons learned to inform maternity care from the UK and Ireland confidential enquiries into maternal deaths and morbidity 2009–13. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2015.
Google Scholar
McCowan LM, Harding JE, Stewart AW. Customized birthweight centiles predict SGA pregnancies with perinatal morbidity. BJOG. 2005;112(8):1026–33.
Article
PubMed
Google Scholar
Battin MR, McCowan LM, George-Haddad M, Thompson JM. Fetal growth restriction and other factors associated with neonatal death in New Zealand. Aust N Z J Obstet Gynaecol. 2007;47(6):457–63.
Article
PubMed
Google Scholar
McCowan LM, George-Haddad M, Stacey T, Thompson JM. Fetal growth restriction and other risk factors for stillbirth in a New Zealand setting. Aust N Z J Obstet Gynaecol. 2007;47(6):450–6.
Article
PubMed
Google Scholar
Lees C, Marlow N, Arabin B, Bilardo CM, Brezinka C, Derks JB, Duvekot J, Frusca T, Diemert A, Ferrazzi E, et al. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol. 2013;42(4):400–8.
Article
CAS
PubMed
Google Scholar
Albertsson-Wikland K, Karlberg J. Postnatal growth of children born small for gestational age. Acta Paediatr Suppl. 1997;423:193–5.
Article
CAS
PubMed
Google Scholar
Hack M, Schluchter M, Cartar L, Rahman M, Cuttler L, Borawski E. Growth of very low birth weight infants to age 20 years. Pediatrics. 2003;112(1 Pt 1):e30–8.
Article
PubMed
Google Scholar
Ozanne SE, Fernandez-Twinn D, Hales CN. Fetal growth and adult diseases. Semin Perinatol. 2004;28(1):81–7.
Article
PubMed
Google Scholar
Barker DJ. The developmental origins of well-being. Philos Trans R Soc Lond B Biol Sci. 2004;359(1449):1359–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35(7):595–601.
Article
CAS
PubMed
Google Scholar
Jarvis S, Glinianaia SV, Torrioli MG, Platt MJ, Miceli M, Jouk PS, Johnson A, Hutton J, Hemming K, Hagberg G, et al. Cerebral palsy and intrauterine growth in single births: European collaborative study. Lancet. 2003;362(9390):1106–11.
Article
PubMed
Google Scholar
Groom KM, Poppe KK, North RA, McCowan LM. Small-for-gestational-age infants classified by customized or population birthweight centiles: impact of gestational age at delivery. Am J Obstet Gynecol. 2007;197(3):239. e231-235.
Article
PubMed
Google Scholar
Engineer N, Kumar S. Perinatal variables and neonatal outcomes in severely growth restricted preterm fetuses. Acta Obstet Gynecol Scand. 2010;89(9):1174–81.
Article
PubMed
Google Scholar
Regev RH, Lusky A, Dolfin T, Litmanovitz I, Arnon S, Reichman B, Israel Neonatal N. Excess mortality and morbidity among small-for-gestational-age premature infants: a population-based study. J Pediatr. 2003;143(2):186–91.
Article
PubMed
Google Scholar
Padilla-Gomes NF, Enriquez G, Acosta-Rojas R, Perapoch J, Hernandez-Andrade E, Gratacos E. Prevalence of neonatal ultrasound brain lesions in premature infants with and without intrauterine growth restriction. Acta Paediatr. 2007;96(11):1582–7.
Article
PubMed
Google Scholar
Vintzileos AM, Ananth CV. First trimester prediction of ischemic placental disease. Semin Perinatol. 2014;38(3):159–66.
Article
PubMed
Google Scholar
McCowan LM, Thompson JM, Taylor RS, North RA, Poston L, Baker PN, Myers J, Roberts CT, Dekker GA, Simpson NA, et al. Clinical prediction in early pregnancy of infants small for gestational age by customised birthweight centiles: findings from a healthy nulliparous cohort. PLoS One. 2013;8(8):e70917.
Article
CAS
PubMed
PubMed Central
Google Scholar
Duffett L, Rodger M. LMWH to prevent placenta-mediated pregnancy complications: an update. Br J Haematol. 2015;168(5):619–38.
Article
CAS
PubMed
Google Scholar
Hnat MD, Sibai BM, Caritis S, Hauth J, Lindheimer MD, MacPherson C, VanDorsten JP, Landon M, Miodovnik M, Paul R, et al. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol. 2002;186(3):422–6.
Article
PubMed
Google Scholar
Makkonen N, Heinonen S, Kirkinen P. Obstetric prognosis in second pregnancy after preeclampsia in first pregnancy. Hypertens Pregnancy. 2000;19(2):173–81.
Article
CAS
PubMed
Google Scholar
Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol. 1986;155(5):1011–6.
Article
CAS
PubMed
Google Scholar
van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol. 2006;195(3):723–8.
Article
PubMed
Google Scholar
Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, Group PC. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369(9575):1791–8.
Article
CAS
PubMed
Google Scholar
Duley L, Henderson-Smart DJ, Knight M, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2004;1:CD004659.
Google Scholar
Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–99.
Article
PubMed
Google Scholar
Quenby S, Mountfield S, Cartwright JE, Whitley GS, Vince G. Effects of low-molecular-weight and unfractionated heparin on trophoblast function. Obstet Gynecol. 2004;104(2):354–61.
Article
CAS
PubMed
Google Scholar
Bose P, Black S, Kadyrov M, Weissenborn U, Neulen J, Regan L, Huppertz B. Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. Am J Obstet Gynecol. 2005;192(1):23–30.
Article
CAS
PubMed
Google Scholar
Bose P, Black S, Kadyrov M, Bartz C, Shlebak A, Regan L, Huppertz B. Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro. Am J Obstet Gynecol. 2004;191(6):2125–31.
Article
CAS
PubMed
Google Scholar
Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996;174(5):1584–9.
Article
CAS
PubMed
Google Scholar
Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997;314(7076):253–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol. 2002;100(3):408–13.
CAS
PubMed
Google Scholar
Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, Kingdom JC, Barrett J, Gent M. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol. 2009;36(2):279–87.
Article
CAS
PubMed
Google Scholar
North RA, Ferrier C, Gamble G, Fairley KF, Kincaid-Smith P. Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease. Aust N Z J Obstet Gynaecol. 1995;35(4):357–62.
Article
CAS
PubMed
Google Scholar
Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, Scarselli GF, Gensini GF, Abbate R. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension. 2005;45(1):86–91.
Article
CAS
PubMed
Google Scholar
Kupferminc MJ, Fait G, Many A, Lessing JB, Yair D, Bar-Am A, Eldor A. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy. 2001;20(1):35–44.
Article
CAS
PubMed
Google Scholar
Riyazi N, Leeda M, de Vries JI, Huijgens PC, van Geijn HP, Dekker GA. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol. 1998;80(1):49–54.
Article
CAS
PubMed
Google Scholar
Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N, Morin F, Demers C, Kahn SR, Magee LA, et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost. 2009;7(1):58–64.
Article
CAS
PubMed
Google Scholar
de Vries JI, van Pampus MG, Hague WM, Bezemer PD, Joosten JH, Investigators F. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. J Thromb Haemost. 2012;10(1):64–72.
Article
PubMed
Google Scholar
Martinelli I, Ruggenenti P, Cetin I, Pardi G, Perna A, Vergani P, Acaia B, Facchinetti F, La Sala GB, Bozzo M, et al. Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood. 2012;119(14):3269–75.
Article
CAS
PubMed
PubMed Central
Google Scholar
Haddad B, Winer N, Chitrit Y, Houfflin-Debarge V, Chauleur C, Bages K, Tsatsaris V, Gris JC, Bastuji-Garin S. LB1: Prevention of maternal and perinatal complications by enoxaparin in women with previous severe preeclampsia (hepepe): an open-label, multicenter, prospective, randomized, controlled trial. Am J Obstet Gynecol. 2016;214(1):S452.
Rodger MA, Hague WM, Kingdom J, Kahn SR, Karovitch A, Sermer M, Clement AM, Coat S, Chan WS, Said J, et al. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. Lancet. 2014;384(9955):1673–83.
Article
CAS
PubMed
Google Scholar
Sanofi-Aventis New Zealand limited. CLEXANE and CLEXANE FORTE. 2016. http://www.medsafe.govt.nz/profs/datasheet/c/clexaneinj.pdf Accessed: 21 July 2016.
Australasian Society for Ultrasound in Medicine (ASUM). Statement on Normal Ultrasonic Fetal Measurements. 2001. http://www.asum.com.au/files/public/SoP/D7-Statement-on-Normal-Ultrasound-Fetal-Measurements.pdf Accessed: 26 July 2016.
Salomon LJ, Alfirevic Z, Berghella V, Bilardo C, Hernandez-Andrade E, Johnsen SL, Kalache K, Leung KY, Malinger G, Munoz H, et al. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2011;37(1):116–26.
Article
CAS
PubMed
Google Scholar
Bhide A, Acharya G, Bilardo CM, Brezinka C, Cafici D, Hernandez-Andrade E, Kalache K, Kingdom J, Kiserud T, Lee W, et al. ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol. 2013;41(2):233–9.
Article
CAS
PubMed
Google Scholar
Anderson NH, Sadler LC, Stewart AW, McCowan LM. Maternal and pathological pregnancy characteristics in customised birthweight centiles and identification of at-risk small-for-gestational-age infants: a retrospective cohort study. BJOG. 2012;119(7):848–56.
Article
CAS
PubMed
Google Scholar
Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, Zeeman GG, Brown MA. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97–104.
CAS
PubMed
Google Scholar